A chain of catalysts lies in front of us for sever
Post# of 30029
Posted On: 01/13/2015 11:48:12 AM
A chain of catalysts lies in front of us for several months that should keep the stock price moving up without reversing the trend. There may be some significant ups and downs in a day, but the trend upward has started and I don't see it stopping for months!
Why? Because no sooner than we move up based on one catalyst, as the stock did yesterday and today as a result of our purchase of the MS drug, but then a new catalyst comes along that keeps us from correcting, and continues the upward trend.
Later today we have the panel with John Commissiong and Dr. Lowe as well as the Eltoprazine presentation later on. I suspect between these 2 events today enough additional fuel will be added to the fire that the stock price will continue to go up.
Tomorrow is LymPro day. That speaks for itself. Then after this week we will get more updates on Wolframs and the Spin Off as well as the Concussion Conference at the end of the month. There could be a huge catalyst coming from that if Dr. Stern announces that revenue from Lympro from the concussion diagnostic will also start later in 2015!!
And then we will continue to hear of more and more pharmas signing up to use Lympro in the AD clinical trials. That will continually fuel the stock price.
And then in Feb or Mar Eltoprazine starts it's phase 2b trial, and soon after that ESS starts it's trial.
So if Biotechexpert tries to convince anyone that this is going to correct significantly for very long.....listen to him at your peril.
Why? Because no sooner than we move up based on one catalyst, as the stock did yesterday and today as a result of our purchase of the MS drug, but then a new catalyst comes along that keeps us from correcting, and continues the upward trend.
Later today we have the panel with John Commissiong and Dr. Lowe as well as the Eltoprazine presentation later on. I suspect between these 2 events today enough additional fuel will be added to the fire that the stock price will continue to go up.
Tomorrow is LymPro day. That speaks for itself. Then after this week we will get more updates on Wolframs and the Spin Off as well as the Concussion Conference at the end of the month. There could be a huge catalyst coming from that if Dr. Stern announces that revenue from Lympro from the concussion diagnostic will also start later in 2015!!
And then we will continue to hear of more and more pharmas signing up to use Lympro in the AD clinical trials. That will continually fuel the stock price.
And then in Feb or Mar Eltoprazine starts it's phase 2b trial, and soon after that ESS starts it's trial.
So if Biotechexpert tries to convince anyone that this is going to correct significantly for very long.....listen to him at your peril.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼